-
RESI Conference Sep 2018 – Deal and Product Valuations
RESI Conference, Boston, Sep 2018, 36 pages Deal and Product Valuations Deal and Product Valuations
-
Whitepaper: The Rise of Bigger, Earlier M&A Deals for Biotech
Continuing a trend that began in 2017, this year has seen the rise of big … Read more
-
Site Selection Report for Life Sciences Companies in Europe 2018
The new Site Selection Report for Life Sciences Companies in Europe, compiled by KPMG in … Read more
-
RESI Conference June 2018 – Deal and Product Valuations
RESI Conference, Boston, June 2018, 36 pages Deal and Product Valuations
-
How to value a Biotech Start-up company
Biotech Investment Showcase, London, May 2018, 22 pages How to value a Biotech Start-up company
-
RESI Conference April 2018 – Deal and Product Valuations
RESI Conference, Toronto, April 2018, 36 pages Deal and Product Valuations
-
Industry Insight: Valuations
BIO-Europe Spring, Amsterdam March 2018, 12 pages Industry Insight: Valuations
-
Interviews with leading Life Sciences companies: Megakaryon Corporation
Current transfusion medicine entirely relies on donated blood. Megakaryon will change the transfusion practices by … Read more
-
Interviews with leading Life Sciences companies: tella inc.
Leveraging its proprietary technology of culturing highly purified dendritic cells (DCs), tella is developing, as … Read more
-
The Launch of the BioAlberta Life Sciences Database
Zurich, Edmonton January 2018 BioAlberta, a Canadian life sciences industry organization, has recently become a … Read more